Pablo Hernán Sotelo Torres
Biographic Data
| ID | 9063809 |
|---|---|
| NAME | Pablo Hernán Sotelo Torres |
| GIVEN NAMES | Pablo Hernán Sotelo |
| FAMILY NAME | Torres |
| SIGNATURE | TORRES P H S |
| VERIFIED | No |
| TOTAL WORKS | 2 |
| TOTAL CITATIONS | 0 |
| WORKS AS AUTHOR | 0 |
| WORKS AS EDITOR | 2 |
| FIRST PUBLICATION YEAR | 2024 |
| LATEST PUBLICATION YEAR | 2026 |
| H-INDEX | 0 |
Phenotypic impacts of treatment-selected mutations in HIV-2 protease on darunavir and lopinavir susceptibility
Compared to HIV-1, HIV-2 infection is characterized by lower viral loads and slower decline in CD4 cells, however the majority of people living with HIV-2 (PLWH2) progress to AIDS and will benefit from antiretroviral therapy. Mutations leading to protease inhibitor (PI) resistance in HIV-2 are poorly characterized, but have important implications for second-line therapy. We evaluated the phenotypic drug susceptibility impacts of HIV-2 protease ch…
Host immune players and their response to Hepatitis C therapies
This study aimed to investigate alterations in the expression of four key cytokines (IL-7, IL-11, IL-15, and IL-27) and assess differential FAM26F expression in response to Hepatitis C virus (HCV) infection. Additionally, it sought to analyze changes in these cytokines after treatment in 244 chronic HCV patients and 28 controls undergoing various treatments, including standard interferon, pegylated interferon, and Direct Acting Antivirals (DAAs).…
No prominent works on this page.
Host immune players and their response to Hepatitis C therapies
This study aimed to investigate alterations in the expression of four key cytokines (IL-7, IL-11, IL-15, and IL-27) and assess differential FAM26F expression in response to Hepatitis C virus (HCV) infection. Additionally, it sought to analyze changes in these cytokines after treatment in 244 chronic HCV patients and 28 controls undergoing various treatments, including standard interferon, pegylated interferon, and Direct Acting Antivirals (DAAs).…
Phenotypic impacts of treatment-selected mutations in HIV-2 protease on darunavir and lopinavir susceptibility
Compared to HIV-1, HIV-2 infection is characterized by lower viral loads and slower decline in CD4 cells, however the majority of people living with HIV-2 (PLWH2) progress to AIDS and will benefit from antiretroviral therapy. Mutations leading to protease inhibitor (PI) resistance in HIV-2 are poorly characterized, but have important implications for second-line therapy. We evaluated the phenotypic drug susceptibility impacts of HIV-2 protease ch…
Darunavir (1 work) · Drug resistance (1 work) · Genotype (1 work) · Hepatitis B Virus Studies (1 work) · Hepatitis C virus research (1 work) · HIV Research and Treatment (1 work) · HIV/AIDS drug development and treatment (1 work) · HIV/AIDS Research and Interventions (1 work) · Host response (1 work) · Immune system (1 work)